TERRA TECH CORP. (OTCMKTS:TRTC) Files An 8-K Regulation FD Disclosure

0

TERRA TECH CORP. (OTCMKTS:TRTC) Files An 8-K Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure.

On June 8, 2017, Terra Tech Corp. (the Company) issued a press
release announcing that its Chief Executive Officer, Mr. Derek
Peterson, has been chosen as a panelist at both the Cannabis
World Congress Business Expo, and the 6th Annual Marcum Microcap
Conference, to be held on Thursday, June 15, 2017 in New York
City. A copy of the press release is attached hereto as Exhibit
99.1 and is incorporated herein by reference.

The information contained in this Item 7.01, and in Exhibit 99.1,
referenced herein is being furnished and shall not be deemed
“filed” for the purposes of Section 18 of the Securities Exchange
Act or incorporated by reference in any filing under the
Securities Act, unless the Company expressly so incorporates such
information by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits:

Exhibit

Description

99.1

Press Release, dated June 8, 2017


About TERRA TECH CORP. (OTCMKTS:TRTC)

Terra Tech Corp. is a cannabis-focused agriculture company. The Company operates through two segments: Hydroponic Produce and Cannabis Products. The Company, through its subsidiary, GrowOp Technology Ltd., is engaged in the design, marketing and sale of hydroponic equipment. It is also a retail seller of locally grown hydroponic produce, herbs, and floral products through its subsidiary, Edible Garden Corp. (Edible Garden). It intends to operate medical marijuana cultivation, production and dispensary facilities in Nevada through its subsidiaries, MediFarm, LLC (MediFarm), MediFarm I, LLC (MediFarm I) and MediFarm II, LLC (MediFarm II). Through its subsidiary, IVXX, Inc. (IVXX), it produces and sells a line of cannabis flowers and cigarettes, among others. The hydroponic produce segment consists of Edible Garden’s business and operations. Its cannabis products segment consists of IVXX’s business, as well as the proposed business operations of MediFarm, MediFarm I and MediFarm II.